-
1
-
-
0003484109
-
-
Philadelphia: Lippincott, Williams & Wilkins
-
Brodeur GMJ. Neuroblastoma. Philadelphia: Lippincott, Williams & Wilkins; 2002.
-
(2002)
Neuroblastoma
-
-
Brodeur, G.M.J.1
-
2
-
-
0003942865
-
-
National Cancer Institute, SEER Program, Bethesda, Maryland, USA
-
Goodman MTGJ, Smith MA, Olshan AF. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995; National Cancer Institute, SEER Program, Bethesda, Maryland, USA; 1999; 65-72.
-
(1999)
Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995
, pp. 65-72
-
-
Goodman, M.T.G.J.1
Smith, M.A.2
Olshan, A.F.3
-
3
-
-
2342458330
-
A halt to neuroblastoma screening in Japan
-
Tsubono Y, Hisamichi S. A halt to neuroblastoma screening in Japan. N Engl J Med 2004; 350:2010-2011.
-
(2004)
N Engl J Med
, vol.350
, pp. 2010-2011
-
-
Tsubono, Y.1
Hisamichi, S.2
-
4
-
-
0031961810
-
131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma
-
Matthay KK, DeSantes K, Hasegawa B, et al. Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma. J Clin Oncol 1998; 16:229-236. (Pubitemid 28041603)
-
(1998)
Journal of Clinical Oncology
, vol.16
, Issue.1
, pp. 229-236
-
-
Matthay, K.K.1
Desantes, K.2
Hasegawa, B.3
Huberty, J.4
Hattner, R.S.5
Ablin, A.6
Reynolds, C.P.7
Seeger, R.C.8
Weinberg, V.K.9
Price, D.10
-
5
-
-
0033034390
-
Molecular biology of neuroblastoma
-
Maris JM, Matthay KK. Molecular biology of neuroblastoma. J Clin Oncol 1999; 17:2264-2279.
-
(1999)
J Clin Oncol
, vol.17
, pp. 2264-2279
-
-
Maris, J.M.1
Matthay, K.K.2
-
6
-
-
0347419432
-
Pediatric neuroblastomas: Genetic and epigenetic 'danse macabre'
-
van Noesel MM, Versteeg R. Pediatric neuroblastomas: genetic and epigenetic 'danse macabre'. Gene 2004; 325:1-15.
-
(2004)
Gene
, vol.325
, pp. 1-15
-
-
Van Noesel, M.M.1
Versteeg, R.2
-
7
-
-
0033551393
-
The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: Function and regulation
-
DOI 10.1038/sj.onc.1202750
-
Luscher B, Larsson LG. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation. Oncogene 1999; 18:2955-2966. (Pubitemid 29276536)
-
(1999)
Oncogene
, vol.18
, Issue.19
, pp. 2955-2966
-
-
Luscher, B.1
Larsson, L.-G.2
-
8
-
-
0021276218
-
Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc
-
Schwab M, Varmus HE, Bishop JM, et al. Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc. Nature 1984; 308:288-291. (Pubitemid 14132037)
-
(1984)
Nature
, vol.308
, Issue.5956
, pp. 288-291
-
-
Schwab, M.1
Varmus, H.E.2
Bishop, J.M.3
-
9
-
-
0028305310
-
MYCN is retained in single copy at chromosome 2 band p23-24 during amplification in human neuroblastoma cells
-
DOI 10.1073/pnas.91.12.5523
-
Corvi R, Amler LC, Savelyeva L, et al. MYCN is retained in single copy at chromosome 2 band p23-24 during amplification in human neuroblastoma cells. Proc Natl Acad Sci U S A 1994; 91:5523-5527. (Pubitemid 24174360)
-
(1994)
Proceedings of the National Academy of Sciences of the United States of America
, vol.91
, Issue.12
, pp. 5523-5527
-
-
Corvi, R.1
Amler, L.C.2
Savelyeva, L.3
Gehring, M.4
Schwab, M.5
-
10
-
-
0022388606
-
Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas
-
Seeger RC, Brodeur GM, Sather H, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985; 313:1111-1116. (Pubitemid 16216827)
-
(1985)
New England Journal of Medicine
, vol.313
, Issue.18
, pp. 1111-1116
-
-
Seeger, R.C.1
Brodeur, G.M.2
Sather, H.3
-
11
-
-
0031417653
-
Evidence that the MYCN oncogene regulates MRP gene expression in neuroblastoma
-
Norris MD, Bordow SB, Haber PS, et al. Evidence that the MYCN oncogene regulates MRP gene expression in neuroblastoma. Eur J Cancer 1997; 33:1911-1916.
-
(1997)
Eur J Cancer
, vol.33
, pp. 1911-1916
-
-
Norris, M.D.1
Bordow, S.B.2
Haber, P.S.3
-
12
-
-
0036168999
-
Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastoma
-
Shohet JM, Hicks MJ, Plon SE, et al. Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastoma. Cancer Res 2002; 62:1123-1128.
-
(2002)
Cancer Res
, vol.62
, pp. 1123-1128
-
-
Shohet, J.M.1
Hicks, M.J.2
Plon, S.E.3
-
13
-
-
0028944776
-
Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma
-
Caron H. Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma. Med Pediatr Oncol 1995; 24:215-221.
-
(1995)
Med Pediatr Oncol
, vol.24
, pp. 215-221
-
-
Caron, H.1
-
14
-
-
0023901480
-
Expression of Ha-ras oncogene products in human neuroblastomas and the significant correlation with a patient's prognosis
-
Tanaka T, Slamon DJ, Shimoda H, et al. Expression of Ha-ras oncogene products in human neuroblastomas and the significant correlation with a patient's prognosis. Cancer Res 1988; 48:1030-1034. (Pubitemid 18061907)
-
(1988)
Cancer Research
, vol.48
, Issue.4
, pp. 1030-1034
-
-
Tanaka, T.1
Slamon, D.J.2
Shimoda, H.3
Waki, C.4
Kawaguchi, Y.5
Tanaka, Y.6
Ida, N.7
-
15
-
-
0029764825
-
Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis
-
Ryden M, Sehgal R, Dominici C, et al. Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis. Br J Cancer 1996; 74:773-779. (Pubitemid 26300770)
-
(1996)
British Journal of Cancer
, vol.74
, Issue.5
, pp. 773-779
-
-
Ryden, M.1
Sehgal, R.2
Dominici, C.3
Schilling, F.H.4
Ibanez, C.F.5
Kogner, P.6
-
16
-
-
0037112433
-
Resistance to chemotherapy mediated by TrkB in neuroblastomas
-
Ho R, Eggert A, Hishiki T, et al. Resistance to chemotherapy mediated by TrkB in neuroblastomas. Cancer Res 2002; 62:6462-6466. (Pubitemid 35364107)
-
(2002)
Cancer Research
, vol.62
, Issue.22
, pp. 6462-6466
-
-
Ho, R.1
Eggert, A.2
Hishiki, T.3
Minturn, J.E.4
Ikegaki, N.5
Foster, P.6
Camoratto, A.M.7
Evans, A.E.8
Brodeur, G.M.9
-
17
-
-
0025801099
-
Age dependence and prognostic impact of neuron specific enolase (NSE) in children with neuroblastoma
-
Berthold F, Engelhardt-Fahrner U, Schneider A, et al. Age dependence and prognostic impact of neuron specific enolase (NSE) in children with neuroblastoma. In Vivo 1991; 5:245-247.
-
(1991)
In Vivo
, vol.5
, pp. 245-247
-
-
Berthold, F.1
Engelhardt-Fahrner, U.2
Schneider, A.3
-
18
-
-
0022443640
-
The use and significance of biologic markers in the evaluation and staging of a child with cancer
-
Woods WG. The use and significance of biologic markers in the evaluation and staging of a child with cancer. Cancer 1986; 58:442-448.
-
(1986)
Cancer
, vol.58
, pp. 442-448
-
-
Woods, W.G.1
-
19
-
-
0027205062
-
Correlation between morphologic and other prognostic markers of neuroblastoma. A study of histologic grade, DNA index, N-myc gene copy number, and lactic dehydrogenase in patients in the Pediatric Oncology Group
-
Joshi VV, Cantor AB, Brodeur GM, et al. Correlation between morphologic and other prognostic markers of neuroblastoma. A study of histologic grade, DNA index, N-myc gene copy number, and lactic dehydrogenase in patients in the Pediatric Oncology Group. Cancer 1993; 71:3173-3181.
-
(1993)
Cancer
, vol.71
, pp. 3173-3181
-
-
Joshi, V.V.1
Cantor, A.B.2
Brodeur, G.M.3
-
20
-
-
0025804903
-
Models to predict outcome from childhood neuroblastoma: The role of serum ferritin and tumor histology
-
Silber JH, Evans AE, Fridman M. Models to predict outcome from childhood neuroblastoma: the role of serum ferritin and tumor histology. Cancer Res 1991; 51:1426-1433.
-
(1991)
Cancer Res
, vol.51
, pp. 1426-1433
-
-
Silber, J.H.1
Evans, A.E.2
Fridman, M.3
-
21
-
-
0025979843
-
Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: A Pediatric Oncology Group study
-
Look AT, Hayes FA, Shuster JJ, et al. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol 1991; 9:581-591.
-
(1991)
J Clin Oncol
, vol.9
, pp. 581-591
-
-
Look, A.T.1
Hayes, F.A.2
Shuster, J.J.3
-
22
-
-
36048999440
-
Alternative TrkAIII splicing: A potential regulated tumor-promoting switch and therapeutic target in neuroblastoma
-
Tacconelli A, Farina AR, Cappabianca L, et al. Alternative TrkAIII splicing: a potential regulated tumor-promoting switch and therapeutic target in neuroblastoma. Future Oncol 2005; 1:689-698.
-
(2005)
Future Oncol
, vol.1
, pp. 689-698
-
-
Tacconelli, A.1
Farina, A.R.2
Cappabianca, L.3
-
23
-
-
17444408934
-
Adhesion molecule CD44 as a prognostic factor in laryngeal cancer
-
Esteban F, Bravo JJ, Gonzalez-Moles MA, et al. Adhesion molecule CD44 as a prognostic factor in laryngeal cancer. Anticancer Res 2005; 25:1115-1121. (Pubitemid 40546889)
-
(2005)
Anticancer Research
, vol.25
, Issue.2 A
, pp. 1115-1121
-
-
Esteban, F.1
Bravo, J.J.2
Gonzalez-Moles, M.A.3
Bravo, M.4
Ruiz-Avila, I.5
Gil-Montoya, J.A.6
-
24
-
-
26844531391
-
Biochemical and molecular markers in renal cell carcinoma: An update and future prospects
-
DOI 10.1080/13547500500218534
-
Kashyap MK, Kumar A, Emelianenko N, et al. Biochemical and molecular markers in renal cell carcinoma: an update and future prospects. Biomarkers 2005; 10:258-294. (Pubitemid 41448389)
-
(2005)
Biomarkers
, vol.10
, Issue.4
, pp. 258-294
-
-
Kashyap, M.K.1
Kumar, A.2
Emelianenko, N.3
Kashyap, A.4
Kaushik, R.5
Huang, R.6
Khullar, M.7
Sharma, S.K.8
Singh, S.K.9
Bhargave, A.K.10
Upadhyaya, S.K.11
-
25
-
-
0031427274
-
Clinical relevance of CD44 cell surface expression and MYCN gene amplification in neuroblastoma
-
DOI 10.1016/S0959-8049(97)00236-0, PII S0959804997002360
-
Combaret V, Gross N, Lasset C, et al. Clinical relevance of CD44 cell surface expression and MYCN gene amplification in neuroblastoma. Eur J Cancer 1997; 33:2101-2105. (Pubitemid 28123464)
-
(1997)
European Journal of Cancer
, vol.33
, Issue.12
, pp. 2101-2105
-
-
Combaret, V.1
Gross, N.2
Lasset, C.3
Frappaz, D.4
Beretta-Brognara, C.5
Philip, T.6
Beck, D.7
Favrot, M.C.8
-
26
-
-
0031427369
-
Correlation of MYCN amplification, trk-A and CD44 expression with clinical stage in 250 patients with neuroblastoma
-
DOI 10.1016/S0959-8049(97)00211-6, PII S0959804997002116
-
Kramer K, Cheung NK, Gerald WL, et al. Correlation of MYCN amplification, Trk-A and CD44 expression with clinical stage in 250 patients with neuroblastoma. Eur J Cancer 1997; 33:2098-2100. (Pubitemid 28123463)
-
(1997)
European Journal of Cancer
, vol.33
, Issue.12
, pp. 2098-2100
-
-
Kramer, K.1
Cheung, N.-K.V.2
Gerald, W.L.3
Laquaglia, M.4
Kushner, B.H.5
Leclerc, J.-M.6
Lesauter, L.7
Saragovi, H.U.8
-
27
-
-
4944248113
-
Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma
-
DOI 10.1158/0008-5472.CAN-04-0695
-
Wei JS, Greer BT, Westermann F, et al. Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma. Cancer Res 2004; 64:6883-6891. (Pubitemid 39330995)
-
(2004)
Cancer Research
, vol.64
, Issue.19
, pp. 6883-6891
-
-
Wei, J.S.1
Greer, B.T.2
Westermann, F.3
Steinberg, S.M.4
Son, C.-G.5
Chen, Q.-R.6
Whiteford, C.C.7
Bilke, S.8
Krasnoselsky, A.L.9
Cenacchi, N.10
Catchpoole, D.11
Berthold, F.12
Schwab, M.13
Khan, J.14
-
28
-
-
58149289668
-
High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours
-
The above article provides data that support the concept that amplification of ALK supports unfavorable neuroblastomas
-
Caren H, Abel F, Kogner P, Martinsson T. High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours. Biochem J 2008; 416:153-159. The above article provides data that support the concept that amplification of ALK supports unfavorable neuroblastomas.
-
(2008)
Biochem J
, vol.416
, pp. 153-159
-
-
Caren, H.1
Abel, F.2
Kogner, P.3
Martinsson, T.4
-
29
-
-
54049094708
-
Identification of ALK as a major familial neuroblastoma predisposition gene
-
The above article solidifies the argument that heritable mutations of ALK are a cause of familial neuroblastoma, and activating mutations can also be somatically acquired
-
Mosse YP, Laudenslager M, Longo L, et al. Identification of ALK as a major familial neuroblastoma predisposition gene. Nature 2008; 455:930-935. The above article solidifies the argument that heritable mutations of ALK are a cause of familial neuroblastoma, and activating mutations can also be somatically acquired.
-
(2008)
Nature
, vol.455
, pp. 930-935
-
-
Mosse, Y.P.1
Laudenslager, M.2
Longo, L.3
-
30
-
-
23944491610
-
A review of DNA microarray analysis of human neuroblastomas
-
DOI 10.1016/j.canlet.2005.01.054, PII S0304383505003605
-
Ohira M, Oba S, Nakamura Y, et al. A review of DNA microarray analysis of human neuroblastomas. Cancer Lett 2005; 228:5-11. (Pubitemid 41188419)
-
(2005)
Cancer Letters
, vol.228
, Issue.1-2
, pp. 5-11
-
-
Ohira, M.1
Oba, S.2
Nakamura, Y.3
Hirata, T.4
Ishii, S.5
Nakagawara, A.6
-
31
-
-
34247884577
-
Cyclin D1, a novel molecular marker of minimal residual disease, in metastatic neuroblastoma
-
DOI 10.2353/jmoldx.2007.060130
-
Cheung IY, Feng Y, Vickers A, et al. Cyclin D1, a novel molecular marker of minimal residual disease, in metastatic neuroblastoma. J Mol Diagn 2007; 9:237-241. (Pubitemid 47305091)
-
(2007)
Journal of Molecular Diagnostics
, vol.9
, Issue.2
, pp. 237-241
-
-
Cheung, I.Y.1
Feng, Y.2
Vickers, A.3
Gerald, W.4
Cheung, N.-K.V.5
-
32
-
-
0027239723
-
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment
-
Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993; 11:1466-1477. (Pubitemid 23228250)
-
(1993)
Journal of Clinical Oncology
, vol.11
, Issue.8
, pp. 1466-1477
-
-
Brodeur, G.M.1
Pritchard, J.2
Berthold, F.3
Carlsen, N.L.T.4
Castel, V.5
Castleberry, R.P.6
De Bernardi, B.7
Evans, A.E.8
Favrot, M.9
Hedborg, F.10
Kaneko, M.11
Kemshead, J.12
Lampert, F.13
Lee, R.E.J.14
Look, A.T.15
Pearson, A.D.J.16
Philip, T.17
Roald, B.18
Sawada, T.19
-
33
-
-
52449119961
-
Case selection in minimally invasive surgical treatment of neuroblastoma
-
An interesting retrospective institutional review of neuroblastoma patients who underwent minimally invasive surgical resection of their primary tumors with safe and effective results
-
Boutros J, Bond M, Beaudry P, et al. Case selection in minimally invasive surgical treatment of neuroblastoma. Pediatr Surg Int 2008; 24:1177-1180. An interesting retrospective institutional review of neuroblastoma patients who underwent minimally invasive surgical resection of their primary tumors with safe and effective results.
-
(2008)
Pediatr Surg Int
, vol.24
, pp. 1177-1180
-
-
Boutros, J.1
Bond, M.2
Beaudry, P.3
-
34
-
-
33750469049
-
Resection of neurogenic tumors in children: Is thoracoscopy superior to thoracotomy?
-
Petty JK, Bensard DD, Partrick DA, et al. Resection of neurogenic tumors in children: is thoracoscopy superior to thoracotomy? J Am Coll Surg 2006; 203:699-703.
-
(2006)
J Am Coll Surg
, vol.203
, pp. 699-703
-
-
Petty, J.K.1
Bensard, D.D.2
Partrick, D.A.3
-
35
-
-
0036188828
-
Lessons learned from a failed multiinstitutional randomized controlled study
-
Ehrlich PF, Newman KD, Haase GM, et al. Lessons learned from a failed multiinstitutional randomized controlled study. J Pediatr Surg 2002; 37:431-436.
-
(2002)
J Pediatr Surg
, vol.37
, pp. 431-436
-
-
Ehrlich, P.F.1
Newman, K.D.2
Haase, G.M.3
-
36
-
-
51649114851
-
Patterns of local recurrence after intraoperative radiotherapy for advanced neuroblastoma
-
A retrospective institutional review of neuroblastoma patients who underwent intraoperative radiation therapy as part of multimodal treatment and were found to have recurrence, which indicates standard radiation therapy as the current treatment of choice
-
Kunieda E, Hirobe S, Kaneko T, et al. Patterns of local recurrence after intraoperative radiotherapy for advanced neuroblastoma. Jpn J Clin Oncol 2008; 38:562-566. A retrospective institutional review of neuroblastoma patients who underwent intraoperative radiation therapy as part of multimodal treatment and were found to have recurrence, which indicates standard radiation therapy as the current treatment of choice.
-
(2008)
Jpn J Clin Oncol
, vol.38
, pp. 562-566
-
-
Kunieda, E.1
Hirobe, S.2
Kaneko, T.3
-
37
-
-
11144310118
-
Radiographic assessment of resectability of locoregional disease in children with high-risk neuroblastoma during neoadjuvant chemotherapy
-
Davidoff AM, Corey BL, Hoffer FA, et al. Radiographic assessment of resectability of locoregional disease in children with high-risk neuroblastoma during neoadjuvant chemotherapy. Pediatr Blood Cancer 2005; 44:158-162.
-
(2005)
Pediatr Blood Cancer
, vol.44
, pp. 158-162
-
-
Davidoff, A.M.1
Corey, B.L.2
Hoffer, F.A.3
-
38
-
-
29144520567
-
The impact of early resection of primary neuroblastoma on the survival of children older than 1 year of age with stage 4 disease: The St. Jude Children's Research Hospital Experience
-
McGregor LM, Rao BN, Davidoff AM, et al. The impact of early resection of primary neuroblastoma on the survival of children older than 1 year of age with stage 4 disease: the St. Jude Children's Research Hospital Experience. Cancer 2005; 104:2837-2846.
-
(2005)
Cancer
, vol.104
, pp. 2837-2846
-
-
McGregor, L.M.1
Rao, B.N.2
Davidoff, A.M.3
-
39
-
-
0034633959
-
Effector mechanisms of fenretinide-induced apoptosis in neuroblastoma
-
DOI 10.1006/excr.2000.4988
-
Lovat PE, Ranalli M, Annichiarrico-Petruzzelli M, et al. Effector mechanisms of fenretinide-induced apoptosis in neuroblastoma. Exp Cell Res 2000; 260:50-60. (Pubitemid 30761496)
-
(2000)
Experimental Cell Research
, vol.260
, Issue.1
, pp. 50-60
-
-
Lovat, P.E.1
Ranalli, M.2
Annichiarrico-Petruzzelli, M.3
Bernassola, F.4
Piacentini, M.5
Malcolm, A.J.6
Pearson, A.D.J.7
Melino, G.8
Redfern, C.P.F.9
-
40
-
-
0032853334
-
Antisense oligonucleotides as therapeutic agents
-
Galderisi U, Cascino A, Giordano A. Antisense oligonucleotides as therapeutic agents. J Cell Physiol 1999; 181:251-257.
-
(1999)
J Cell Physiol
, vol.181
, pp. 251-257
-
-
Galderisi, U.1
Cascino, A.2
Giordano, A.3
-
41
-
-
33947153003
-
Inhibitors of histone deacetylases as potential therapeutic tools for high-risk embryonal tumors of the nervous system of childhood
-
DOI 10.1002/ijc.22401
-
Furchert SE, Lanvers-Kaminsky C, Juurgens H, et al. Inhibitors of histone deacetylases as potential therapeutic tools for high-risk embryonal tumors of the nervous system of childhood. Int J Cancer 2007; 120:1787-1794. (Pubitemid 46399367)
-
(2007)
International Journal of Cancer
, vol.120
, Issue.8
, pp. 1787-1794
-
-
Furchert, S.E.1
Lanvers-Kaminsky, C.2
Jurgens, H.3
Jung, M.4
Loidl, A.5
Fruhwald, M.C.6
-
42
-
-
56449109565
-
Hypoxia-mediated induction of the polyamine system provides opportunities for tumor growth inhibition by combined targeting of vascular endothelial growth factor and ornithine decarboxylase
-
The above article indicates combined targeted therapy against VEGF and ODC as an alternative strategy to treat solid malignancies
-
Svensson KJ, Welch JE, Kucharzewska P, et al. Hypoxia-mediated induction of the polyamine system provides opportunities for tumor growth inhibition by combined targeting of vascular endothelial growth factor and ornithine decarboxylase. Cancer Res 2008; 68:9291-9301. The above article indicates combined targeted therapy against VEGF and ODC as an alternative strategy to treat solid malignancies.
-
(2008)
Cancer Res
, vol.68
, pp. 9291-9301
-
-
Svensson, K.J.1
Welch, J.E.2
Kucharzewska, P.3
-
43
-
-
13844272288
-
Antiangiogenic strategies in neuroblastoma
-
Ribatti D, Ponzoni M. Antiangiogenic strategies in neuroblastoma. Cancer Treat Rev 2005; 31:27-34.
-
(2005)
Cancer Treat Rev
, vol.31
, pp. 27-34
-
-
Ribatti, D.1
Ponzoni, M.2
-
44
-
-
0030034892
-
Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma
-
Meitar D, Crawford SE, Rademaker AW, Cohn SL. Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma. J Clin Oncol 1996; 14:405-414. (Pubitemid 26051001)
-
(1996)
Journal of Clinical Oncology
, vol.14
, Issue.2
, pp. 405-414
-
-
Meitar, D.1
Crawford, S.E.2
Rademaker, A.W.3
Cohn, S.L.4
-
45
-
-
0034081340
-
Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in human neuroblastomas
-
DOI 10.1002/(SICI)1096-911X(200006)34:6<386::AID-MPO2>3.0.CO;2-3
-
Langer I, Vertongen P, Perret J, et al. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in human neuroblastomas. Med Pediatr Oncol 2000; 34:386-393. (Pubitemid 30346403)
-
(2000)
Medical and Pediatric Oncology
, vol.34
, Issue.6
, pp. 386-393
-
-
Langer, I.1
Vertongen, P.2
Perret, J.3
Fontaine, J.4
Atassi, G.5
Robberecht, P.6
-
46
-
-
0036894805
-
Expression of vascular endothelial growth factor and its receptor Flk-1 in human neuroblastoma using in situ hybridization
-
DOI 10.1053/jpsu.2002.36712
-
Fukuzawa M, Sugiura H, Koshinaga T, et al. Expression of vascular endothelial growth factor and its receptor Flk-1 in human neuroblastoma using in situ hybridization. J Pediatr Surg 2002; 37:1747-1750. (Pubitemid 35416929)
-
(2002)
Journal of Pediatric Surgery
, vol.37
, Issue.12
, pp. 1747-1750
-
-
Fukuzawa, M.1
Sugiura, H.2
Koshinaga, T.3
Ikeda, T.4
Hagiwara, N.5
Sawada, T.6
-
47
-
-
51349137154
-
Gastrin-releasing peptide receptor silencing suppresses the tumorigenesis and metastatic potential of neuroblastoma
-
An important study highlighting GRP-R deficiency, which results in significant delays in neuroblastoma tumor growth and decreased liver metastases in vivo, therefore providing a novel therapeutic target
-
Qiao J, Kang J, Ishola TA, et al. Gastrin-releasing peptide receptor silencing suppresses the tumorigenesis and metastatic potential of neuroblastoma. Proc Natl Acad Sci U S A 2008; 105:12891-12896. An important study highlighting GRP-R deficiency, which results in significant delays in neuroblastoma tumor growth and decreased liver metastases in vivo, therefore providing a novel therapeutic target.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, pp. 12891-12896
-
-
Qiao, J.1
Kang, J.2
Ishola, T.A.3
-
48
-
-
46249116654
-
N-myc is a novel regulator of PI3K-mediated VEGF expression in neuroblastoma
-
DOI 10.1038/onc.2008.15, PII ONC200815
-
Kang J, Rychahou PG, Ishola TA, et al. N-myc is a novel regulator of PI3K-mediated VEGF expression in neuroblastoma. Oncogene 2008; 27:3999-4007. MYCN siRNA significantly blocked VEGF secretion in MYCN-amplified neuroblastoma cells; mammalian target of rapamycin (mTOR) inhibitor synergistically enhanced this effect. (Pubitemid 351913633)
-
(2008)
Oncogene
, vol.27
, Issue.28
, pp. 3999-4007
-
-
Kang, J.1
Rychahou, P.G.2
Ishola, T.A.3
Mourot, J.M.4
Evers, B.M.5
Chung, D.H.6
-
50
-
-
34347348018
-
Bombesin induces angiogenesis and neuroblastoma growth
-
DOI 10.1016/j.canlet.2007.02.007, PII S030438350700050X
-
Kang J, Ishola TA, Baregamian N, et al. Bombesin induces angiogenesis and neuroblastoma growth. Cancer Lett 2007; 253:273-281. (Pubitemid 47017542)
-
(2007)
Cancer Letters
, vol.253
, Issue.2
, pp. 273-281
-
-
Kang, J.1
Ishola, T.A.2
Baregamian, N.3
Mourot, J.M.4
Rychahou, P.G.5
Evers, B.M.6
Chung, D.H.7
-
51
-
-
34247248710
-
Phosphatidylinositol 3-kinase regulation of gastrin-releasing peptide-induced cell cycle progression in neuroblastoma cells
-
DOI 10.1016/j.bbagen.2007.02.002, PII S0304416507000426
-
Ishola TA, Kang J, Qiao J, et al. Phosphatidylinositol 3-kinase regulation of gastrin-releasing peptide-induced cell cycle progression in neuroblastoma cells. Biochim Biophys Acta 2007; 1770:927-932. (Pubitemid 46617033)
-
(2007)
Biochimica et Biophysica Acta - General Subjects
, vol.1770
, Issue.6
, pp. 927-932
-
-
Ishola, T.A.1
Kang, J.2
Qiao, J.3
Evers, B.M.4
Chung, D.H.5
-
52
-
-
34248575347
-
Retinoids as differentiating agents in oncology: A network of interactions with intracellular pathways as the basis for rational therapeutic combinations
-
DOI 10.2174/138161207780618786
-
Garattini E, Gianni M, Terao M. Retinoids as differentiating agents in oncology: a network of interactions with intracellular pathways as the basis for rational therapeutic combinations. Curr Pharm Des 2007; 13:1375-1400. (Pubitemid 46758854)
-
(2007)
Current Pharmaceutical Design
, vol.13
, Issue.13
, pp. 1375-1400
-
-
Garattini, E.1
Gianni, M.2
Terao, M.3
-
53
-
-
0344394175
-
Retinoids in cancer therapy and chemoprevention: Promise meets resistance
-
DOI 10.1038/sj.onc.1206936, Drug Resistance
-
Freemantle SJ, Spinella MJ, Dmitrovsky E. Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene 2003; 22:7305-7315. (Pubitemid 37487162)
-
(2003)
Oncogene
, vol.22
, Issue.47 REV. ISS. 6
, pp. 7305-7315
-
-
Freemantle, S.J.1
Spinella, M.J.2
Dmitrovsky, E.3
-
54
-
-
0033554684
-
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid
-
Children's Cancer Group
-
Matthay KK, Villablanca JG, Seeger RC, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 1999; 341:1165-1173.
-
(1999)
N Engl J Med
, vol.341
, pp. 1165-1173
-
-
Matthay, K.K.1
Villablanca, J.G.2
Seeger, R.C.3
-
55
-
-
0037634528
-
D2 immunotherapy
-
DOI 10.1097/00043426-200307000-00003
-
Kushner BH, Kramer K, LaQuaglia MP, Cheung NK. Curability of recurrent disseminated disease after surgery alone for local-regional neuroblastoma using intensive chemotherapy and anti-G(D2) immunotherapy. J Pediatr Hematol Oncol 2003; 25:515-519. (Pubitemid 36830697)
-
(2003)
Journal of Pediatric Hematology/Oncology
, vol.25
, Issue.7
, pp. 515-519
-
-
Kushner, B.H.1
Kramer, K.2
Laquaglia, M.P.3
Cheung, N.-K.V.4
-
56
-
-
0037372307
-
Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma
-
DOI 10.1182/blood-2002-08-2493
-
Rousseau RF, Haight AE, Hirschmann-Jax C, et al. Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma. Blood 2003; 101:1718-1726. (Pubitemid 36237566)
-
(2003)
Blood
, vol.101
, Issue.5
, pp. 1718-1726
-
-
Rousseau, R.F.1
Haight, A.E.2
Hirschmann-Jax, C.3
Yvon, E.S.4
Rill, D.R.5
Mei, Z.6
Smith, S.C.7
Inman, S.8
Cooper, K.9
Alcoser, P.10
Grilley, B.11
Gee, A.12
Popek, E.13
Davidoff, A.14
Bowman, L.C.15
Brenner, M.K.16
Strother, D.17
-
57
-
-
55549145071
-
Virus-specific T cells engineered to coexpress tumor-specific receptors: Persistence and antitumor activity in individuals with neuroblastoma
-
An important immunotherapy study in patients demonstrating cytotoxic T lymphocytes directed to GD2 was safe and associated with tumor regression or necrosis
-
Pule MA, Savoldo B, Myers GD, et al. Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma. Nat Med 2008; 14:1264-1270. An important immunotherapy study in patients demonstrating cytotoxic T lymphocytes directed to GD2 was safe and associated with tumor regression or necrosis.
-
(2008)
Nat Med
, vol.14
, pp. 1264-1270
-
-
Pule, M.A.1
Savoldo, B.2
Myers, G.D.3
-
58
-
-
27144507056
-
Gene manipulation to enhance MIBG-targeted radionuclide therapy
-
DOI 10.1016/j.nucmedbio.2005.03.011, PII S0969805105000818
-
Mairs RJ, Fullerton NE, Cosimo E, Boyd M. Gene manipulation to enhance MIBG-targeted radionuclide therapy. Nucl Med Biol 2005; 32:749-753. (Pubitemid 41502981)
-
(2005)
Nuclear Medicine and Biology
, vol.32
, Issue.7
, pp. 749-753
-
-
Mairs, R.J.1
Fullerton, N.E.2
Cosimo, E.3
Boyd, M.4
-
59
-
-
0345074094
-
131I-metaiodobenzylguanidine
-
DOI 10.1002/cncr.11167
-
Garaventa A, Gambini C, Villavecchia G, et al. Second malignancies in children with neuroblastoma after combined treatment with 131I- metaiodobenzylguanidine. Cancer 2003; 97:1332-1338. (Pubitemid 36237321)
-
(2003)
Cancer
, vol.97
, Issue.5
, pp. 1332-1338
-
-
Garaventa, A.1
Gambini, C.2
Villavecchia, G.3
Di Cataldo, A.4
Bertolazzi, L.5
Pizzitola, M.R.6
De Bernardi, B.7
Haupt, R.8
-
60
-
-
20544448435
-
Aggressive surgical therapy and radiotherapy for patients with high-risk neuroblastoma treated with rapid sequence tandem transplant
-
DOI 10.1016/j.jpedsurg.2005.03.008, PII S0022346805002009
-
von Allmen D, Grupp S, Diller L, et al. Aggressive surgical therapy and radiotherapy for patients with high-risk neuroblastoma treated with rapid sequence tandem transplant. J Pediatr Surg 2005; 40:936-941. (Pubitemid 40840808)
-
(2005)
Journal of Pediatric Surgery
, vol.40
, Issue.6
, pp. 936-941
-
-
Von Allmen, D.1
Grupp, S.2
Diller, L.3
Marcus, K.4
Ecklund, K.5
Meyer, J.6
Shamberger, R.C.7
|